US regulator FDA has told Pharmaxis (ASX:PXS) that it will likely need to conduct a new phase III trial before Bronchitol can be approved as a cystic fibrosis treatment. [ + ]

iSonea (ASX:ISN) has used an Asthma Foundation conference to unveil AsthmaSense Cloud, a system for cloud storage and transfer of wheeze monitoring data. [ + ]

Collaborators from Mayo-Illinois Alliance for Technology Based Healthcare have developed a new, single molecule test for detecting methylated DNA. [ + ]

Researchers at The University of Western Australia and the Western Australian Institute for Medical Research have revealed a groundbreaking new molecular structure formed by two human proteins involved in turning genes on and off in cancer. [ + ]

Ondek has appointed a new chief executive as it continues development of a drug delivery platform based on the research of its Nobel Laureate founder. [ + ]

The TGA and Medsafe are inviting comment on a consultation document for the trans-Tasman early warning system of safety concerns with medicines and medical devices. [ + ]

The alarming rate at which the malaria parasite is developing resistance to drugs may be countered by changing the timing of the drug treatment and developing drugs that last longer in the bloodstream. [ + ]

Professor Georg Melchers, from the University of Basel in Switzerland, is in Sydney to discuss biologics and the treatment of autoimmune diseases. [ + ]

Digital planetariums worldwide have snapped up a fulldome movie produced by The University of Western Australia (UWA) which uses stunning simulations made inside supercomputers to explain the science around dark matter - the missing 80% of the universe’s mass. [ + ]

A study in the latest issue of STEM CELLS Translational Medicine shows how stem cells can be used to successfully repair the mandible after a molar extraction and that, years later, the new bone is still functioning properly. [ + ]

Lonza Walkersville and Hyglos GmbH have reached a mutually beneficial global settlement which includes a licence agreement for Hyglos under certain Lonza patents in the area of endotoxin detection. [ + ]

The US FDA will decide by 26 August whether to approve QRxPharma’s revised application for approval of its dual-opioid pain patch. [ + ]

Insulating cells - the cells that protect our nerves - can be made and added to the central nervous system throughout our lifetime. There is now evidence that these cells may not be the passive bystanders to brain function that we once thought. [ + ]

Mesoblast (ASX:MSB) has filled its coffers to the tune of $170m through a private placement in order to help raise funds for upcoming clinical trials of its adult stem cells. [ + ]

Australian shareholders are being given the opportunity to buy into Biolife Science with a vaccine that shows potential to combat stomach (gastric) and breast cancer. [ + ]